Plants - Drugs Mind - Spirit Freedom - Law Arts - Culture Library  
References Database

References Search
All References with Titles containing 'Plat_L' OR with Authors including 'Plat_L' OR with Abstract including 'Plat_L' OR with Keywords including 'Plat_L'

Author Title JournalName Year   D
Click on Column Headers to Re-Sort The Current List
Carlsson A, Shore PA, Bro... Release of serotonin from blood platelets by reserpine in vitro J. Pharmacol. Exper.... 1957
Stacey RS Uptake of 5-hydroxytryptamine by platelets Brit. J. Pharmacol. 1961
Michal F D-Receptor for serotonin on blood platelets Nature 1969
Michal F Platelet aggregation by very low intensity acoustical energy and its i... Brit. J. Pharmacol. 1970
Gillis CN Metabolism of Vasoactive Hormones by Lung. Anesthesiology 1973
Torre M, Bogetto F, Torte... Effect of LSD-25 and l-Methyl-d-Lysergic Acid Butanolamide on Rat Brai... Psychopharmacologia ... 1974
Fanchamps A The Role of Humoral Mediators in Migraine Headache J Canad Sci Neurol 1975
Drummond AH, Gordon JL Inhibition of 5-Hydroxy-(3H)-tryptamine Binding to Rat Blood Platelets... Brit.J.Pharmacol. 1975
Klock JC, Boerner U, Beck... Coma, Hyperthermia, and Bleeding Associated with Massive LSD Overdose,... Clinical Toxicology 1975
Saito H, Kitagawa H Mechanisms of the reversal of blood pressure by ephedrine Jap.J.Pharmacol. 1976
Boullin DJ, Glenton PAM Characterization of Receptors Mediating 5-Hydroxytryptamine and Catech... Brit.J.Pharmacol. 1978
Graf M, Pletscher A Pharmacological characterization of the 5-hydroxytryptamine (5HT) rece... Experientia (Basel) 1978
Da Prada M, Pieri L, Kell... Effects of 5,6-Dihydroxytryptamine and 5,7-Dihydroxytryptamine on the ... Ann.N.Y.Acad.Sci. 1978
Graf M, Pletscher A Shape Change Of Blood Platelets - a Model For Cerebral 5-hydroxytrypta... Brit.J.Pharmacol. 1979
Laubscher A, Pletscher A Shape Change And Uptake Of 5-hydroxytryptamine In Human Blood Platelet... Life Sci. 1979
Laubscher A, Pletscher A,... Blood platelets as models for neurons: receptor- and nonreceptor-media... Experientia 1980
Laubscher A, Pletscher A Increase of cyclic GMP in blood platelets by biogenic amines - a recep... J.Pharm.Pharmacol. 1980
Laubscher A, Pletscher A,... Interaction of D-LSD with Blood Platelets of Rabbits: Shape Change and... J Pharm and Exp Ther... 1981
Leysen JE, Gommeren W Characterization and quantification of serotonin-S2 receptor sites on ... Archives Internation... 1984
Leysen JE, De Chaffoy De ... Serotonin-s2 Receptor Binding Sites And Functional Correlates Neuropharmacology 1984
Geaney DP, Schachter M, E... Characterisation of [3H]Lysergic Acid Diethylamide Binding to a 5-Hydr... Europ J Pharmacol 1984
Schachter M, Geaney DP, G... Increased platelet membrane [3H]-LSD binding in patients on chronic ne... Br. J. Clin. Pharmac... 1985
Schachter M, Godfrey PP, ... Serotonergic Agonists Stimulate Inositol Lipid Metabolism In Rabbit Pl... Life Sciences 1985
Mathews JD, Riley MD, Fej... Effects of the heavy usage of kava on physical health: summary of a pi... Med J Aust 1988
Cozzi NV, Sievert MK, Shu... Methcathinone and 2-methylamino-1-(3,4-methylenedioxyphenyl)propan-1-o... Soc. Neurosci. Abs 1988
Britt SG, Gonias SL, Sand... Agonist and antagonist activities of arylpiperazines at human platelet... J Pharmacol Exp Ther 1988
Nash JF, Arora RC, Schrei... Effect of 3,4-methylenedioxymethamphetamine on [3H]paroxetine binding ... Biochem Pharmacol 1991
Rudnick G, Wall SC The molecular mechanism of 'ecstasy' [3,4-methylenedioxymethamphetamin... Proc Natl Acad Sci 1992
Rudnick G, Wall SC Non-neurotoxic Amphetamine Derivatives Release Serotonin through Serot... Mol Pharmacol 1993
Schuldiner S, Steiner-Mor... Amphetamine Derivatives Interact with Both Plasma Membrane and Secreto... Mol Pharmacol 1993
Shih JC, Chen K, Gallaher... Structure and Function of Serotonin 5-HT2 Receptors NIDA Research Monogr... 1994
Skop BP, Finkelstein JA, ... The serotonin syndrome associated with paroxetine, an over-the-counter... Am J Emerg Med 1994
Williams A, Unwin R Prolonged elevation of serum creatine kinase (CK) without renal failur... Nephrol Dial Transpl... 1997
Gleitz J, Beile A, Wilken... Antithrombotic action of the kava pyrone (+)-kavain prepared from Pipe... Planta Med 1997
Van Cauter E, Plat L, Sch... Simultaneous stimulation of slow-wave sleep and growth hormone secreti... J Clin Invest 1997
Mathews JD, Riley MD, Fej... Effects of the heavy usage of kava on physical health: summary of a pi... Med J Aust 1998
Cozzi NV, Shulgin AT, Ruo... Methcathinone (MCAT) and 2-methylamino-1-(3,4-methylenedioxyphenyl)pro... Amer. Chem. Soc. Div... 1998
Schirren CA, Berghaus TM,... Thrombotic thrombocytopenic purpura after Ecstasy-induced acute liver ... Ann Intern Med 1999
Cozzi NV, Sievert MK, Shu... Inhibition of plasma membrane monoamine transporters by beta-ketoamphe... Eur J Pharmacol 1999
Cozzi NV, Foley KF Methcathinone is a substrate for the serotonin uptake transporter Pharmacol Toxicol 2003
Ding EL, Hutfless SM, Din... Chocolate and prevention of cardiovascular disease: a systematic revie... Nutr Metab (Lond) 2006
Rose DZ, Guerrero WR, Mok... Hemorrhagic stroke following use of the synthetic marijuana spice Neurology 2015